GS
Graig Suvannavejh Mizuho Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Insmed
INSM
$31B
| $146.59 | $165 |
13%
upside
| Outperform | 21 days ago |
|
2 |
2
Alector
ALEC
$277M
| $2.74 | $3.50 |
28%
upside
| Outperform | 1 month ago |
|
3 |
3
Neumora Therapeutics
NMRA
$292M
| $1.80 | $5 |
178%
upside
| Outperform | 1 month ago |
|
4 |
4
Corvus Pharmaceuticals
CRVS
$428M
| $5.74 | $11 |
92%
upside
| Outperform | 3 months ago |
|
5 |
5
EyePoint Pharmaceuticals
EYPT
$823M
| $11.94 | $26 |
118%
upside
| Outperform | 3 months ago |
|
6 |
6
Harmony Biosciences
HRMY
$2.14B
| $37.27 | $48 |
29%
upside
| Outperform | 3 months ago |
|
7 |
7
Apellis Pharmaceuticals
APLS
$3.57B
| $28.27 | $20 |
29%
downside
| Neutral | 3 months ago |
|
8 |
8
Amylyx Pharmaceuticals
AMLX
$885M
| $9.92 | $8 |
19%
downside
| Outperform | 3 months ago |
|
9 |
9
Immunocore
IMCR
$1.71B
| $34.02 | $33 |
3%
downside
| Neutral | 4 months ago |
|
10 |
10
Axsome Therapeutics
AXSM
$6.18B
| $123.75 | $216 |
75%
upside
| Outperform | 5 months ago |
|
11 |
AUTL
11
Autolus Therapeutics
AUTL
$407M
| $1.53 | $7.60 |
397%
upside
| Buy | 9 months ago |
|
12 |
12
Halozyme
HALO
$8.68B
| $74.20 | $49 |
34%
downside
| Neutral | 1 year ago |
|
13 |
13
IDEAYA Biosciences
IDYA
$2.33B
| $26.54 | $50 |
88%
upside
| Outperform | 1 year ago |
|
14 |
14
Immatics
IMTX
$681M
| $5.60 | $16 |
186%
upside
| Buy | 1 year ago |
|
15 |
15
Terns Pharmaceuticals
TERN
$666M
| $7.61 | $10 |
31%
upside
| Buy | 1 year ago |
|
16 |
16
Rhythm Pharmaceuticals
RYTM
$6.94B
| $104.47 | $35 |
67%
downside
| Buy | 2 years ago |
|
17 |
17
Kodiak Sciences
KOD
$451M
| $8.53 | $8 |
6%
downside
| Neutral | 2 years ago |
|
18 |
18
Cytokinetics
CYTK
$5.93B
| $49.53 | $57 |
15%
upside
| Buy | 3 years ago |
|
19 |
19
TG Therapeutics
TGTX
$5.03B
| $31.72 | $5 |
84%
downside
| Sell | 3 years ago |
|
20 |
VALN
20
Valneva
VALN
$758M
| $8.91 | $34 |
282%
upside
| Buy | 4 years ago |
|
21 |
21
Design Therapeutics
DSGN
$328M
| $5.76 | $28 |
386%
upside
| Neutral | 4 years ago |
|
22 |
22
Edgewise Therapeutics
EWTX
$1.56B
| $14.79 | $31 |
110%
upside
| Neutral | 4 years ago |
|
23 |
23
Vor Biopharma
VOR
$264M
| $2.08 | $19 |
813%
upside
| Sell | 4 years ago |
|
24 |
24
Terns Pharmaceuticals
TERN
$666M
| $7.61 | $29 |
281%
upside
| Buy | 4 years ago |
|
25 |
25
Immunocore
IMCR
$1.71B
| $34.02 | $40 |
18%
upside
| Neutral | 4 years ago |
|